Metanalyses in patients with severe sepsis or septic shock have reported a significant reduction in all-cause mortality, reduced incidence of MODS, and reduced duration of mechanical ventilation with ulinastatin and with a combination of thymosin alpha-1 (Tα1) and ulinastatin [9,10]. The gene discussed is TAAR1; the disease is Sepsis.